Company intelligence / Profile preview

Indigo Science

State College, Pennsylvania, United Statespmc.ncbi.nlm.nih.gov ↗

Ownership: Private
Employees: ~14
Development stage: Commercial

Overview

INDIGO Biosciences offers the world’s largest portfolio of cell-based nuclear receptor reporter assays and in vitro toxicology solutions. Their proprietary CryoMite™ process enables robust, ready-to-use cryopreserved cells for rapid functional screening. Their products are widely used by pharmaceutical, biotech, academic, government, food/agriculture/nutraceutical sectors to accelerate drug discovery and safety testing with high reproducibility and sensitivity. No clinical results as they are a service/tools provider.

Modalities: Small moleculeBiologicReporter gene assayCell-based assay
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Indigo Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Indigo Science.

Explore the full profile